Ep 40 Checkmate 238 Post Recurrence Outcomes

Summary In this

Summary In this

Paolo Ascierto, MD, Istituto Tumori Fondazione Pascale, Naples, Italy, presents 7-year

Jeffrey Weber, MD, PhD, of Perlmutter Cancer Center, New York, NY, updates us on the 4-year follow-up

Jeffrey S. Weber, MD, PhD, deputy director of the Laura and Isaac Perlmutter Cancer Center, co-director of the Melanoma ...

Paolo Ascierto, MD, Istituto Tumori Fondazione Pascale, Naples, Italy, comments on the final nine-year

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses how the

Paolo Ascierto, MD, National Tumor Institute, Milan, Italy, presents the

touchONCOLOGY talks to Jeffrey S Weber from the Laura and Isaac Perlmutter Cancer Cente and NYU Langone Medical Center ...

Oncoinfo – Istantanee di Oncologia medica: seguici su www.oncoinfo.it] Jeffrey Weber (Deputy Director and Head - Perlmutter ...

Jeffrey S. Weber, MD, PhD, deputy director and co-director of the Melanoma Program at the Laura and Isaac Perlmutter Cancer ...

This Q & A with Dr. Hans Hammers, a lead investigator in the phase 3

Dr. Thierry André from Hôpital Saint-Antoine gives an overview of the

Michael Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the overall survival (OS)

At the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, Matthew Galsky, MD, of Icahn School of ...

Jeffrey Weber, MD, PhD, NYU Langone Medical Center, New York City, NY, discusses the

Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Department of Medicine and Ludwig Center at ...

Recorded @ ESMO 2022, Sunday September 11.

Elizabeth Plimack, MD, MS, Fox Chase Cancer Centre, Philadelphia, PA, discusses updated

Jeffrey S. Weber, MD, PhD, deputy director and co-director of the Melanoma Program at the Laura and Isaac Perlmutter Cancer ...